The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

37 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors.EBI
Chia Tai Tianqing Pharmaceutical Group
Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity.EBI
Chia Tai Tianqing Pharmaceutical Group
FUSED BICYCLIC COMPOUND CONTAINING PYRROLINONEBDB
Chia Tai Tianqing Pharmaceutical Group
POLYAMIDE COMPOUNDS, METHOD FOR PREPARING SAME, AND MEDICAL USE THEREOFBDB
Jiangsu Nhwa Pharmaceutical Co.
NOVEL BENZOTHIOPHENE DERIVATIVE AND USE THEREOF AS BET INHIBITORBDB
Benobio Co.
Aminonorbornane derivative and manufacture method therefor and use thereofBDB
Transthera Sciences (Nanjing)
Cyclobutyl dihydroquinoline sulfonamide compoundsBDB
Amgen
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofBDB
Nurix Therapeutics
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofBDB
Genentech
SMALL-MOLECULAR INHIBITORS FOR THE BETA-CATENIN/ B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTIONBDB
H. Lee Moffitt Cancer Center and Research Institute
Pyrazolo compounds and methods of use thereofBDB
Genentech
6-AMINOPYRAZOLOPYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOFBDB
Japan Tobacco
NAMPT MODULATORSBDB
Cytokinetics, Incorporated
FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENSBDB
University of Illinois
SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASEBDB
Individual
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related theretoBDB
Arena Pharmaceuticals
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORSBDB
Theravance Biopharma R&D Ip
HETEROARYLQUINAZOLINE COMPOUNDS AS PROTEIN KINASE INHIBITORSBDB
Chengdu Cynogen Bio-Pharmaceutical Technology
Methods of inhibiting cyclooxygenaseBDB
King Faisal University
1H-IMIDAZO [4,5-H] QUINAZOLINE COMPOUND AS NOVEL SELECTIVE FLT3 INHIBITORSBDB
Shengke Pharmaceuticals (Jiangsu)
3-(1H-IMIDAZOL-2-YL)-2,3,8,8A-TETRAHYDROINDOLIZIN-5(1H)-ONE DERIVATIVES USEFUL AS FACTOR XIA INHIBITORSBDB
Janssen Pharmaceutica
Azaindole derivatives and their use as ERK kinase inhibitorsBDB
Agv Discovery
KRas G12D inhibitorsBDB
Mirati Therapeutics
Heterocyclic prolinamide derivativesBDB
Orion Ophthalmology
Heterocyclic compounds for the inhibition of PASKBDB
Bioenergenix
Carbazole derivativesBDB
Bristol-Myers Squibb
KV1.3 inhibitors and their medical applicationBDB
4Sc
Compositions useful for treating disorders related to kitBDB
Blueprint Medicines
Oxoisoquinoline derivativesBDB
Carna Biosciences
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseBDB
Eastern Virginia Medical School
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologiesBDB
Galderma Research & Development
Inhibitors of RETBDB
Blueprint Medicines
Synthesis and biological evaluation of novel series of aminopyrimidine derivatives as urease inhibitors and antimicrobial agents.BDB
Solapur University
Triazolopyridinone PDE10 inhibitorsBDB
Merck Sharp & Dohme
Morpholinylbenzotriazines for use in cancer therapyBDB
Merck Patent
Re(I) and Tc(I) complexes for targeting nitric oxide synthase: influence of the chelator in the affinity for the enzyme.BDB
Universidade De Lisboa
Rosuvastatin and atorvastatin derivativesBDB
Redx Pharma